27 unknown. 27 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 27 | Unknown 27 |
Follow Attention Deficit and Disruptive Behavior Disorders: new trials by email Literature Review of Attention Deficit and Disruptive Behavior Disorders trials Research Report on Attention Deficit and Disruptive Behavior Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FASST - Fetal Alcohol Spectrum Stimulant Trial Methylphenidate Hydrochloride, Placebo, Methylphenidate hydrochloride - Fetal Alcohol Spectrum Disorders | Phase 4 | Unknown | Monash Medical Centre | 20 | 2022-02-14 | 2022-12-13 |
| Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder Cariprazine - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Dr. Martin A. Katzman | 15 | 2021-12-01 | 2021-12-14 |
| The Effects of a Single Dose of Methylphenidate on Motor Performance MPH - ADHD | Phase 4 | Unknown | Loewenstein Hospital | 200 | 2021-05-27 | 2023-12-20 |
| Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD Placebos, vitamin AD, vitamin D - ADHD | Phase 4 | Unknown | Chen Li | 504 | 2021-02-25 | 2021-04-06 |
| Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD Foquest - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | JPM van Stralen Medicine Professional | 41 | 2020-12-01 | 2023-09-28 |
| Melatonin in ADHD and Sleep Problems Melatonin 3 mg - Attention Deficit Hyperactivity Disorder, Sleep Disorder | Phase 4 | Unknown | Allan Hvolby | 80 | 2020-09-01 | 2022-05-09 |
| Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk Methylphenidate, Atomoxetine - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Icahn School of Medicine at Mount Sinai | 44 | 2019-06-04 | 2024-08-09 |
| Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children Methylphenidate - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | IRCCS Eugenio Medea | 20 | 2018-04-13 | 2022-08-05 |
| Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD Methylphenidate - ADHD, Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Icahn School of Medicine at Mount Sinai | 500 | 2018-03-04 | 2024-08-09 |
| A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Aptensio XR - Attention Deficit Disorder With Hyperactivity | Phase 4 | Unknown | Rhodes Pharmaceuticals, L.P. | 120 | 2016-09-01 | 2016-08-25 |
| Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder Rhodiola, Placebo - Attention Deficit/Hyperactivity Disorder | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 60 | 2016-04-01 | 2019-05-29 |
| Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder Rhodiola, Placebo - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 60 | 2016-04-01 | 2019-05-29 |
| Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children L. helveticus R0052 and B. longum R0175, Placebo - Attention Deficit Hyperactivity Disorder, Anxiety | Phase 4 | Unknown | Acadia University | 100 | 2015-06-01 | 2015-09-10 |
| Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD Methylphenidate (Concerta) - Attention-deficit/Hyperactivity Disorder | Phase 4 | Unknown | National Taiwan University Hospital | 120 | 2012-08-01 | 2014-02-28 |
| Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers methylphenidate, atomoxetine - Attention-deficit/Hyperactivity Disorder | Phase 4 | Unknown | Seoul National University Childrens Hospital | 400 | 2012-05-01 | 2015-12-07 |
| Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties Melatonin, Methylphenidate - Attention Deficit Hyperactivity Disorder, Sleep Onset Insomnia | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 46 | 2011-06-01 | 2011-07-13 |
| Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD) atomoxetine - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Peking University | 100 | 2011-03-01 | 2011-04-20 |
| Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder Cognitive Behavioural & Skills Training, Supportive Group Therapy, Treatment as Usual - community resources - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 216 | 2010-10-01 | 2018-07-31 |
| International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder Short Acting Methylphenidate, Long Acting Methylphenidate - Attention Deficit/Hyperactivity Disorder | Phase 4 | Unknown | BRC Operations Pty. Ltd. | 1344 | 2009-10-01 | 2018-07-11 |
| Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) Valproate, Risperidone, Placebo - Attention Deficit Disorder With Hyperactivity | Phase 4 | Unknown | Joseph Blader | 270 | 2008-11-01 | 2012-07-16 |
Showing 20 of 27. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (27) · Aggression (2) · Sleep Wake Disorders (2) · Anxiety Disorders (1) · Bipolar Disorder (1) · Conduct Disorder (1) · Fetal Alcohol Spectrum Disorders (1) · Impulsive Behavior (1) · Motor Activity (1) · Oppositional Defiant Disorder (1) · Parasomnias (1) · Sleep Initiation and Maintenance Disorders (1) · Spasm (1) · Tourette Syndrome (1) · Trichotillomania (1)
Mental Disorders (27) · Neurodevelopmental Disorders (27) · Behavior (4) · Nervous System Diseases (4) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Aberrant Motor Behavior in Dementia (2) · Behavioral Symptoms (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Social Behavior (2) · Alcohol-Induced Disorders (1) · Alcohol-Related Disorders (1) · Anxiety Disorders (1)
Methylphenidate (14) · Atomoxetine Hydrochloride (4) · 5,10-dihydro-5-methylphenazine (3) · Dextroamphetamine (2) · Melatonin (2) · Amphetamine (1) · Lisdexamfetamine Dimesylate (1) · Risperidone (1) · SLI381 (1) · Sugars (1) · Therapeutics (1) · Valproic Acid (1) · Vitamin D (1) · cariprazine (1)
Federal University of Rio Grande do Sul (2) · Hospital de Clinicas de Porto Alegre (2) · Icahn School of Medicine at Mount Sinai (2) · Acadia University (1) · Allan Hvolby (1) · Assaf-Harofeh Medical Center (1) · BRC Operations Pty. Ltd. (1) · Chen Li (1) · Dr. Martin A. Katzman (1) · Geha Mental Health Center (1) · IRCCS Eugenio Medea (1) · JPM van Stralen Medicine Professional (1) · Joseph Blader (1) · Laboratoires URGO (1) · Loewenstein Hospital (1)
United States (6) · Canada (5) · Brazil (4) · Israel (3) · Australia (2) · China (2) · South Korea (2) · Denmark (1) · France (1) · Italy (1) · Netherlands (1) · Taiwan (1)
Eugenio Grevet, PhD (2) · Jeffrey Newcorn, MD (2) · Alison Crichton, PhD (1) · Allan Hvolby, MD, Ph.D (1) · Ann Childress, MD (1) · Barbara A. Cohen, PhD (1) · Boong-nyun Kim, MD, PhD (1) · Chi-Yung Shang, M.D., Ph.D. (1) · Claudia M Szobot, MD (1) · Harbans Multani, MD (1) · Iliyan Ivanov, MD (1) · Joseph C. Blader, PhD, MSc (1) · Judith Owens, MD, MPH (1) · Judy van Stralen, MD (1) · Kamran Fallahpour, PhD (1)
PMID 21586916, PMID 24290461, PMID 26745211, PMID 29937325, PMID 32007604, PMID 33892111, PMID 34135055, PMID 37058600, PMID 38631835, PMID 40681145, PMID 41567292, PMID 42620964
R01HD093612 (1), R21DA045218 (1)